20:32 EDT Cathie Wood’s ARK Investment buys 425K shares of Recursion Pharmaceuticals today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Cathie Wood’s ARK Investment buys 124K shares of Recursion Pharmaceuticals today
- Recursion Pharmaceuticals’ Groundbreaking Cancer Drug Enters Clinical Trials
- Recursion receives FDA clearance for Phase 1/2 clinical trial of REC-1245
- Cathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals
- Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals